Related Experiment Video
Updated: May 29, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
[Haemophilus influenzae type b vaccine]
Tomohiro Katsuta1, Akihiko Saitoh
1Department of Medical Specialties, National Center for Child Health and Development.
Abstract:
Haemophilus influenzae type b (Hib) vaccine has been included in the national Immunization Program in more than 120 countries around the world and its effectiveness and safety have been confirmed. In Japan, Hib vaccine was recently licensed in December 2008. Because it has included in the category of voluntary vaccine and the burden of out-of-pocket expense is a major concern for caregivers, payment coverage through the local government funded by the temporal national budget has been initiated since November 2010. It is important to make an effort to fill the "vaccine gap" between Japan and other developed countries and increase a vaccine coverage rate including Hib vaccine to decrease vaccine preventable diseases in Japanese children.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
06:34An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Related Concept Videos
Bacterial Meningitis I: Introduction
Vaccinations
Diphtheria
Bacterial Meningitis
Poliomyelitis
Bacterial Meningitis II: Pathophysiology